Doxorubicin resistance is a major challenge in breast cancer treatment, leading to cancer recurrence and poor therapeutic outcomes. Therefore, new agents that can overcome chemoresistance are urgently needed.
Chemotherapy is widely used as a frontline treatment for breast cancer (BC), but chemoresistance to...
Abdulmajeed M. Jali, Ali Hanbashi, F. Kamli et al.· Pharmacognosy Magazine· 0 citations
Oncoviruses are responsible for a substantial fraction of human cancers and have emerged as critical modulators of host cellular pathways that also govern ageing. The convergence of viral oncogenesis, ageing, and cancer reflects shared molecular mechanisms, including genomic instability, epigenetic alterations, telomer...
N. Allehyani, Mohammed Alissa, Abdullah Alghamdi et al.· Reviews in Medical Virology· 0 citations
CA4 is prioritized as a reproducible LUAD-associated candidate supported by transcriptomic, machine-learning, immune, survival, and docking evidence, but the computational findings do not demonstrate direct phytochemical regulation of CA4 or therapeutic efficacy.
Awaji Y. Safhi, Fahad Y. Sabei, Ali Hanbashi et al.· Journal of Pharmaceutical In...· 0 citations
The work presents a data-driven framework that employs Raman spectroscopy and uncertainty-aware machine learning models to anticipate drug release patterns in different biological media and demonstrates the value of bio-inspired hyperparameter optimization within an uncertainty-aware computational framework.
Ahmed H. Albariqi, Awaji Y. Safhi, Fahad Y. Sabei et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.